5LB and BIOV Related Headlines
Go Back- BioVaxys Technology completes $1.9 million private placement financing
- BioVaxys Technology Corp. Closes Listed Issuer Financing Exemption (LIFE) Private Placement
- BioVaxys Licensee SpayVac-for-Wildlife, Inc., Reports Further Positive Single-Dose Efficacy Data for Its Immunocontraceptive Vaccine and Initiation of Regulatory Submission Process
5LB and BIOV Related Press Releases
Go Back- BioVaxys Technology Corp. Closes Listed Issuer Financing Exemption (LIFE) Private Placement
- BioVaxys Licensee SpayVac-for-Wildlife, Inc., Reports Further Positive Single-Dose Efficacy Data for Its Immunocontraceptive Vaccine and Initiation of Regulatory Submission Process
